Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2025-07-27
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Five-year Mortality Rate in People With Diabetic Foot Ulcer
NCT03782129
Obliterating Diabetic Microangiopathy of the Diabetic Foot
NCT02610036
Effect of New High Ankle Block on Wound Healing After the Operation of Debridement of Diabetes Foot
NCT06395961
Prediction Model for the Risk of Developing Foot Ulcers in Diabetes
NCT07307183
Ulcer Location and Debridement Frequency: Weekly vs. Biweekly Sharp Debridement in Diabetic Foot Ulcers
NCT06160817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will analyze relationships between patient demographics, clinical features, and laboratory findings (including Hb, WBC, HbA1C, ESR, CRP) with ulcer severity based on Wagner's classification. Statistical tests such as independent t-test, chi-square, Fisher's exact test, and multivariable logistic regression will be used.
By identifying key factors associated with ulcer severity and outcomes, the findings of this study may contribute to more effective prevention and management strategies for diabetic foot ulcers, ultimately reducing complications and healthcare costs
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of diabetic foot ulcer (DFU) confirmed by medical records
* Complete demographic, clinical, and laboratory data available in medical files
Exclusion Criteria
* Patients with foot ulcers of non-diabetic etiology
* Patients whose key laboratory data are unavailable
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Golestan University of Medical sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pezhman Kharazm, MD
Assistant Professor of Vascular Surgery, Golestan University of Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
5Th Azar Medical Center
Gorgan, Outside of the US, Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
114627
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.